期刊文献+

原发性高血压肾病患者血浆ET-1和血清APN、CysC检测的临床意义 被引量:6

Clinical Significance of Measuring Changes on Plasma ET-1 and Serum APN CysC,Levels in Patients with Essential Hypertension Complieated with Nephropathy
下载PDF
导出
摘要 目的:探讨原发性高血压肾病患者血浆ET-1和血清APN、CysC水平的变化及临床意义。方法:应用放射免疫分析和酶联法对32例原发性高血压肾病患者进行血浆ET-1和血清APN、CysC检测,并同时与35名正常人作比较。结果:原发性高血压肾病患者血浆ET-1和血清APN、CysC水平显著地高于正常人组(P<0.01),而血清APN水平又非常显著地低于正常人组(P<0.01),血浆ET-1水平与CysC水平呈正相关(r=0.6228,P<0.01),与APN水平呈显著负相关(r=-0.4012,P<0.01)。结论:检测原发性高血压肾病患者血浆ET-1和血清CysC、APN水平的变化,两者均具较高检测率。因此,有助于对疾病进程的评估,包括发病机制、预防和指导用药方针。 Objective To explore the clinical significance of changes on plasma ET-1 and serum CysC, APN levels in patients with essential hypertension complicated with nephropathy. Methods Plasma ET-1(with RIA), serum CysC, APN(with ELISA) levels were measured in 32 patients with essential hypertension complicated with nephropathy prominently and compared to 35 normal controis simultaneously. Results Plasma ET-1 and serum CysC levels were significantly higher in the patients than those in controls(P 〈 0.01 ). while the serum APN level was remarkably lower( P 〈0.01 ). Plasma ET-1 level was positively correlated with CysC( r = 0.6228, P 〈 0.01 ). Plasma ET-1 level was significantly negatively correlated with APN ( r = - 0.4012, P 〈 0.001 ). Conclusion Both the changes of plasma ET-1 and serum GysC, APN levels have high detection rote, thus might be helpful to the assessment of the diseases process, such as pathogenesis, prevention and guidlines foropharmacological therapy.
作者 张春雷
出处 《放射免疫学杂志》 CAS 2013年第3期275-277,共3页 Journal of Radioimmanology
关键词 原发性高血压肾病 内皮素-1 胱抑素C 脂联素 primary hypertension nephropathy, endothelin-1 (ET-1), cystatin C ( CysC), adiponectin(APN)
  • 相关文献

参考文献10

二级参考文献53

共引文献86

同被引文献54

  • 1高四红.原发性高血压患者血清HGF对诊治高血压肾病的临床价值[J].黑龙江医学,2013,37(5):330-331. 被引量:2
  • 2余学清.高血压病肾损害的诊断与治疗[J].中国实用内科杂志,2006,26(3):323-325. 被引量:16
  • 3杨有业,张秀明.临床检验方法学评价[S].北京:人民卫生出版社,2008:48-51. 被引量:1
  • 4Da Silva AS,Dias LD,Borges JF,et al.Renal GLUT1 reduction depends on angiotensin-converting enzyme inhibition in diabetic hypertensive rats[J].Life sciences,2013,26(8):1547-1549 被引量:1
  • 5Knobler H,Bandedy M,Boyko V, et al. Adiponeetion and the devel- opment of diabetes in patients with coronary artery diseases and im- paired fasting glucose [ J ]. Eur J Endocrinal,2006,154 ( 1 ) : 87-2. 被引量:1
  • 6Lee M H, Klein R L, E1 - Shewy H M, et al The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Sre/Ras - depen - dent pathway and stimulate cell growth J 1. Biochemistry,2008, 47(44) :1168-1169. 被引量:1
  • 7Seherer P E. Adipose issue:from lipid storage emnpartment to endo- cline organ E J . Diabetes, 2006,55 ( 6 ) : 1537-1545. 被引量:1
  • 8Koji O,Hirotsugu I, Shinji K, et al. Exacebation of albuminuria and renal fibrosisin subtotal renal ablation model of adiponectin - Knock- out mice [ J ]. Arterioscler Thromb Vasc Biol, 2007,27 (9) : 1910- 1917. 被引量:1
  • 9Zoccali C, Mallamaci F. Adiponectin and leptin in chronic kidney disease:causal factors or mere risk markers [ J ]. J Ren Nutr,2011, 21(1) :87-91. 被引量:1
  • 10Takemura T,Yoshihiro A, Yuji O, et al. Adiponectin receptors, with special focus on the role of the third receptor,T -cadherin,in vascu- lar disease[ J]. Med Mol Morpho1,2007,40 ( 3 ) : 115-120. 被引量:1

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部